Phase 4 Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 6 and 80 years old who have been diagnosed with mild or moderate asthma
Who may not be able to join:
- People with severe asthma or those who have been admitted to an intensive care unit
- People with ischemic heart disease (a condition where the heart does not get enough blood flow)
- People who have recently had abdominal (stomach area) surgery
- People who are unable to correctly perform breathing tests (called pulmonary function tests)
- People with liver or kidney problems
- People who have had an allergic reaction or sensitivity to salbutamol (a common asthma reliever medication, also known as albuterol)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mohamed Emam Abdelrahim, professor, Beni-Suef
Phone: +201152677683
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the total emitted dose; Mass median aerodynamic diameter (MMAD); fine particle dose (FPD); fine particle fraction (FPF); lung bioavailability; systemic bioavailability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.